[Role of osteoclasts in bone destruction in rheumatoid arthritis].
Suzuki
Y
Y
Department of Rheumatic and Allergic Diseases, St. Marianna University School of Medicine.
D001172:Arthritis, Rheumatoid / Q000473:pathology*; D001862:Bone Resorption; D001842:Bone and Bones / Q000473:pathology*; D002352:Carrier Proteins / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics; D002478:Cells, Cultured; D016207:Cytokines / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D008264:Macrophages / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology; D010003:Osteoarthritis / Q000473:pathology; D010010:Osteoclasts / Q000166:cytology / Q000502:physiology*; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D013583:Synovial Membrane / Q000166:cytology / Q000473:pathology
D002352:Carrier Proteins; D016207:Cytokines; D018836:Inflammation Mediators; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human